ASCO Survey on COVID-19 in Oncology (ASCO) Registry

Status unconfirmed

Conditions studied: Neoplasms, Coronavirus

In brief

The American Society of Clinical Oncology (ASCO) Survey on Coronavirus 2019 (COVID-19) in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 is impacting the delivery of cancer care and patient outcomes. The ASCO Registry collects both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 pandemic.

Key facts

Study ID

NCT04659135

Run by

American Society of Clinical Oncology

People needed

7000

Starts

2020-04-19

Expected to finish

2025-01-01

Last updated by the study team

2023-07-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• COVID-19 positive diagnosis
• One of the following;
• Patient has active cancer at the time of COVID-19 diagnosis OR
• Patient has been cancer-free for less than 12 months AND receiving adjuvant therapy at the time of COVID-19 diagnosis

You may not qualify if…

• COVID-19 suspected, but no positive test result
• Patient is a cancer-free not receiving any anti-cancer or adjuvant treatment
• Patient is receiving adjuvant therapy, but has been cancer-free for up to 12 months at the time of COVID-19 diagnosis

Where it is running

• Infirmary Cancer Care — Mobile, Alabama, United States
• Anchorage Oncology Center — Anchorage, Alaska, United States
• AIS Cancer Center — Bakersfield, California, United States
• Long Beach Memorial Medical Center — Fountain Valley, California, United States
• Orange Coast Medical Center — Fountain Valley, California, United States
• Saddleback Memorial Medical Center — Fountain Valley, California, United States
• Helen Diller Family Comprehensive Cancer Center, UCSF — San Francisco, California, United States
• Gene Upshaw Memorial Tahoe Forest Cancer Center — Truckee, California, United States
• PIH Health — Whittier, California, United States
• Hartford HealthCare Cancer Institute — Hartford, Connecticut, United States
• Day Kimball Healthcare — Putnam, Connecticut, United States
• Bayhealth Medical Center — Dover, Delaware, United States
• Florida Precision Oncology, A Division of 21st Centry Oncology — Fort Myers, Florida, United States
• Florida Cancer Specialists - Sarah Cannon Research Institute — Sarasota, Florida, United States
• University of South Florida — Tampa, Florida, United States
• Emory University Winship Cancer Institute — Atlanta, Georgia, United States
• Augusta University — Augusta, Georgia, United States
• Cancer Center of Middle Georgia, LLC — Dublin, Georgia, United States
• Hawaii Cancer Care — Honolulu, Hawaii, United States
• University of Chicago — Chicago, Illinois, United States
• NorthShore University HealthSystem — Evanston, Illinois, United States
• OSF Little Company of Mary Hospital — Evergreen Park, Illinois, United States
• Joliet Oncology-Hematology Associates — Joliet, Illinois, United States
• Edward-Elmhurst Healthcare — Naperville, Illinois, United States
• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.